Results 81 to 90 of about 104,093 (313)

Systematic evaluation of the pharmacoeconomics research on herpes zoster vaccine administration: a systematic review

open access: yesZhongguo gonggong weisheng
ObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU   +4 more
doaj   +1 more source

Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons   +2 more
wiley   +1 more source

Herpes zoster in an immunocompetent adolescent – A case of rare occurrence

open access: yesJournal of Family Medicine and Primary Care
Herpes zoster is an acute viral infection caused by the reactivation of the varicella zoster virus. It occurs commonly in immunocompromised adults. Odontalgia may be an early prodromal symptom when herpes zoster involves the oral and maxillofacial region,
A.Winnifred Christy   +3 more
doaj   +1 more source

Bullous Herpes Zoster

open access: yesActa Dermato-Venereologica, 2000
n ...
Juin Wong, Ke   +4 more
openaire   +4 more sources

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo   +11 more
wiley   +1 more source

Incidence of Herpes Zoster in relationship with Climate Factors from 2009 to 2011

open access: yesAlthea Medical Journal, 2015
Background: Herpes zoster, or shingles, is a skin or mucous infection caused by the reactivation of varicella-zoster virus (VZV). Seasonal pattern of herpes zoster incidence was reported in some countries, indicating that emergence of this disease was ...
Herning Adinda   +2 more
doaj   +1 more source

Successful Treatment of Paediatric Necrobiosis Lipoidica With Baricitinib

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Necrobiosis lipoidica (NL) is a rare, chronic granulomatous condition that typically presents as sharply demarcated plaques with telangiectasia and atrophic centres. Paediatric cases are uncommon, and treatment options often fail to address refractory cases.
P. Simões Farinha, M. J. Paiva‐Lopes
wiley   +1 more source

Construction of risk prediction model for postherpetic neuralgia of patients with herpes zoster

open access: yesHuli yanjiu, 2022
ObjectiveTo analyze the risk factors of postherpetic neuralgia(PHN) of patients with herpes zoster and to construct risk prediction model.Methods425 patients with herpes zoster admitted to department of dermatology of our hospital were selected as study ...
LI Jiao, HUANG Guohui, NI Ping
doaj  

Herpes Zoster Pada Geriatri [PDF]

open access: yes, 2014
Latar belakang. Herpes zoster merupakan penyakit kulit yang bercirikan timbulnya ruam kulit dengan distribusi dermatomal dan disertai rasa nyeri yang hebat.
IV, S. (Saragih)
core  

Home - About - Disclaimer - Privacy